DD239611A5 - Verfahren zur herstellung neuer saframycin a-derivaten - Google Patents

Verfahren zur herstellung neuer saframycin a-derivaten Download PDF

Info

Publication number
DD239611A5
DD239611A5 DD85280121A DD28012185A DD239611A5 DD 239611 A5 DD239611 A5 DD 239611A5 DD 85280121 A DD85280121 A DD 85280121A DD 28012185 A DD28012185 A DD 28012185A DD 239611 A5 DD239611 A5 DD 239611A5
Authority
DD
German Democratic Republic
Prior art keywords
saframycin
glycine
tyrosine
methionine
formula
Prior art date
Application number
DD85280121A
Other languages
German (de)
English (en)
Inventor
Tadashi Arai
Yuzuru Mikami
Original Assignee
Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kk filed Critical Kk
Publication of DD239611A5 publication Critical patent/DD239611A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/56—Streptomyces lavendulae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/899—Streptomyces lavendulae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD85280121A 1984-08-30 1985-08-29 Verfahren zur herstellung neuer saframycin a-derivaten DD239611A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59179292A JPS6158593A (ja) 1984-08-30 1984-08-30 新規サフラマイシンａ誘導体およびその製造法

Publications (1)

Publication Number Publication Date
DD239611A5 true DD239611A5 (de) 1986-10-01

Family

ID=16063271

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85280121A DD239611A5 (de) 1984-08-30 1985-08-29 Verfahren zur herstellung neuer saframycin a-derivaten

Country Status (14)

Country Link
US (1) US4837149A (ja)
EP (1) EP0173649A3 (ja)
JP (1) JPS6158593A (ja)
KR (1) KR860002575A (ja)
DD (1) DD239611A5 (ja)
DK (1) DK391885A (ja)
ES (2) ES8701178A1 (ja)
FI (1) FI853282L (ja)
GR (1) GR852097B (ja)
HU (1) HUT41071A (ja)
IL (1) IL76242A0 (ja)
NO (1) NO853396L (ja)
PT (1) PT81037B (ja)
ZA (1) ZA856598B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0262085A1 (de) * 1986-08-15 1988-03-30 Gesellschaft für Biotechnologische Forschung mbH (GBF) Antibiotika aus Myxococcus
ES2135990B1 (es) 1995-07-13 2000-05-01 Klein Iberica Estructura para el montaje de puertas correderas.
US6124292A (en) * 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
AU3956502A (en) 2000-11-03 2002-05-27 Harvard College Saframycins, analogues and uses thereof
US6964804B2 (en) * 2001-02-14 2005-11-15 Shipley Company, L.L.C. Micromachined structures made by combined wet and dry etching
US7183054B2 (en) 2003-06-03 2007-02-27 President And Fellows Of Harvard College Assay for identifying biological targets of polynucleotide-binding compounds
KR100712667B1 (ko) * 2006-04-11 2007-05-02 재단법인서울대학교산학협력재단 신규한 디아자 헤테로고리 유도체 및 그의 고체상 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5937952B2 (ja) * 1977-09-12 1984-09-12 正 新井 抗生物質サフラマイシンａ，ｂ，ｃ，ｄ，ｅおよびその製造法
JPS56135486A (en) * 1980-03-26 1981-10-22 Tadashi Arai Antibiotic saframycin s and its preparative method
JPS5942382A (ja) * 1982-09-02 1984-03-08 Yoshitomi Pharmaceut Ind Ltd サフラシン誘導体

Also Published As

Publication number Publication date
ES555459A0 (es) 1987-12-01
NO853396L (no) 1986-03-03
EP0173649A3 (en) 1987-08-12
ZA856598B (en) 1986-04-30
KR860002575A (ko) 1986-04-26
GR852097B (ja) 1986-01-02
US4837149A (en) 1989-06-06
ES8800944A1 (es) 1987-12-01
FI853282A0 (fi) 1985-08-28
JPS6158593A (ja) 1986-03-25
ES8701178A1 (es) 1986-11-16
IL76242A0 (en) 1986-01-31
PT81037A (en) 1985-09-01
EP0173649A2 (en) 1986-03-05
ES546574A0 (es) 1986-11-16
FI853282L (fi) 1986-03-01
HUT41071A (en) 1987-03-30
DK391885D0 (da) 1985-08-29
PT81037B (en) 1987-06-24
DK391885A (da) 1986-03-01

Similar Documents

Publication Publication Date Title
EP0739344B1 (en) Antiparasitic pyrrolobenzoxazine compounds
DE2634499C2 (de) Tylosin-Acylderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen und Tierfutterzubereitungen
DE2754326C2 (de) Antibiotikum AM 2282, seine Herstellung und Arzneimittel
DE3836675A1 (de) Glykosidase-inhibitor salbostatin, verfahren zu seiner herstellung und seine verwendung
DE2743654A1 (de) Anthracyclinglycosid
DE2813021A1 (de) Antibiotikum ka-6606
DD239611A5 (de) Verfahren zur herstellung neuer saframycin a-derivaten
DE2715255A1 (de) Anthracyclinglykoside
DE2918711C2 (ja)
DE2839668C2 (ja)
CH646432A5 (de) Beta-lactam-antibiotika.
DE69816621T2 (de) Macrolide mit antitumoraktivität
EP0236894B1 (de) Efomycin G, seine Herstellung und seine Verwendung als Leistungsförderer bei Tieren
EP0652205A2 (de) Moenomycin-Abbauprodukte mit hydroxylierter oder oxidierter Lipidseitenkette und Moenomycin-Analoga, ein Verfahren zur Herstellung und die Verwendung dieser Verbindungen
DE3407979C2 (ja)
DE2654266C3 (de) Verfahren zur mikrobiologischen Herstellung von 5,10,11,1 la-Tetrahydro-9,1 ldihydroxy-e-methyl-Soxo-lH-pyrrolo [2,1-c] [1,4] benzodiazepin-2acrylamid
DE2424707A1 (de) Antibiotikum nr. 1998, seine salze mit saeuren, verfahren zu seiner herstellung, mikroorganismen zur durchfuehrung des verfahrens und arzneimittel
DE2014277A1 (de) Verfahren zur Herstellung von Acylderivaten des Antibiotikums T-2636 C
DE3141168A1 (de) Anthracyclin-verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE60021109T2 (de) Amycomycin, verfahren zu dessen herstellung und seine verwendung als arzneimittel
DE2506986A1 (de) Ionomycin
DE2510868C3 (de) Nanaomycin A und Verfahren zur Herstellung der Antibiorica Nanaomycin A und Nanaomycin B
AT364455B (de) Verfahren zur herstellung von neuen phosphonsaeuren
DE60132703T2 (de) Citrullimycine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CH616958A5 (ja)